Compare AERT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AERT | CCEL |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 32.7M |
| IPO Year | N/A | 2022 |
| Metric | AERT | CCEL |
|---|---|---|
| Price | $0.38 | $3.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 967.4K | 12.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.26 | $3.10 |
| 52 Week High | $1.52 | $7.70 |
| Indicator | AERT | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 41.87 |
| Support Level | $0.26 | $3.13 |
| Resistance Level | $0.55 | $3.57 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 51.73 | 36.10 |
Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.